MTHFR and MTRR gene polymorphic site detection kits (PCR fluorescence dissolutio
MTHFR and MTRR gene polymorphic site detection kits (PCR fluorescence dissolution method)

MTHFR and MTRR gene polymo‌<✘₩rphic site detection kits (PCR fluorescence di↕δ≤ssolution method)

Clinical background

  In the folic ♣'β€acid metabolism pathway, single nucleot♥♦↕ide polymorphisms (SNPs) of methylenet$•etrahydrofolate reductase (MTHFR) and methionin✘Ω♦e synthetase reductase (MTRR) can affectπ‍ the activity of MTHFR and MTRR s∞§≠♥ynthase, and Affects the level of s♠"♥erum folic acid or homocysteine. It will cause§$÷ hypofolate and hyperhomocysteinemia, w ✘←₽hich will increase the risk of birthα∑ defects, neural tube d↔ ↔Ωiseases and cardiovascular↓☆ε≈ diseases in newborns.
  The "China Cardiovascular Disease 2015" re§↓ port shows that: China's cardi$±ovascular disease accounts for the hi¥Ω♣ghest mortality rate of residents in China, and< ÷× the number of cardiovascular patients will con↑✔δ₩tinue to increase in th☆≈₩αe next ten years. At the​₩÷δ same time, there are about 8₩​↔‌00-1.2 million new cases of σ★‌♦birth defects in China every year. The$"<®refore, folic acid gene testing is carried ou★Ωt to personalize folic aci₩♠•d supplementation for people with folic ♣↕acid mutations, so as to fundamenta​★lly prevent the risks of birth defects, n↓ eural tube diseases and cardio☆∑ vascular diseases.


Inspection diagram

Figure 1: Methyltetrahydrolysis (MTHFR)gene C₹'✔§677T(rs1801133) 
Figure 2: Methyl tetrahyd×≥ε✔rofolilic acid reductase (MTHFR)MTHFRgene←→ A1298C(rs1801131) 
Figure 3: Methylthion syntε£λ←hetic reductase (MTR✘≈↕R)MTRRgene A66G(rs1801394)

The Significance of Gene Tes​÷ting
Early detection is caused by genet™'ic factors, which can provide guidan<₩÷•ce for people who lack folic≈ ♦‌ acid to achieve precise medication;
Provide the basis for the onset of hyperhomocyste¶≈★inemia patients;
Defining the family ge​"≈netic history and providing guidance for eugen≥≈ics and personalized medicine;
Gene mutations can be accurately detect‌≠λed.
Product advantages
Comprehensive:The first to detect three major mutations in the±β Chinese population at the same time,​↕↕ enabling a more comprehensive assess↔‌ment of the subject's folic acid util≤"∑ization capacity;
Accurate:Use a large number of clinical samp‌↑εles to verify, and the coincide→↕π☆nce rate with sequencing is 1₽≥∑£00%, to avoid wrong or missed ✔λπ tests;
The operation is simple and fast: one tube detects three sites, which takes les'<s time from the experiment to the results,  ₩♠stable performance, high r>λ♠epeatability, and the test↑&✔ results can be quickly and accurately ★✘><interpreted, simple and ↑₽©βclear;
Genetic testing: Qualitative identificat‍ε←★ion of folic acid risk genes to☆π © achieve personalized folic acid su₩β$pplementation with relia€♠φ♠ble results for life;

High sensitivity:&nbs↑αp;The detection limit of the genomic DNA of the exa≈®¥↔minee is 2ng / μL;


National 973 project, top international and dom>©≠♣estic experts devote themselves to creatin↕♠g


Application areas
Analysis of the causes of hig©♠★&h-like cysteineemia 
Pregnant women: prevention o"γ∏​f birth defects, spontaneous abortion, p♣♣regnancy hypertension, etc. 
Women with a bad pregnancy history: prevention of✘₩ adverse pregnancy recurrence
Product information

Detection of specimens:φ♥'φ Anticoagulant whole bl>₩↕ood or genomic DNA

Technical principle: PCR-fluorescent melting method

Packing size:24 tests / kit,48 tests / kit

Category:In vitro diagnostic <÷φσreagents

Suitable for instruments: Fluorescence quantitativ♣‌↕★e PCR instrument